RWE and HTA – a snapshot of recent developments with Sreeram Ramagopalan: October–November 2021

Written by Written by Sreeram Ramagopalan (F. Hoffmann-La Roche)

RWD

Read highlights from the latest instalment of Sreeram Ramagopalan’s (F. Hoffman La Roche, Basel, Switzerland) industry news round-up, which discusses some of the latest developments regarding real-world evidence (RWE) in the context of health technology assessment (HTA) and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update for October–November 2021 in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? The publication of the Friends of Cancer Research pilot projects. These pilots sought to assess how real-world data (RWD) coming from different electronic health...

To view this content, please register now for access

It's completely free